Applications Are Now Open. The Application Deadline Is 21 January 2022


Identification of genomic features of SARS-CoV-2, and human genetic factors impacting the COVID19 pandemic holds the potential to rapidly offer important information that can be used to manage the outbreak by finding genetic markers for COVID-19 progression in Bahraini population, and biological insights that might point to potential drug targets. In this project, we aim to achieve the following aims:

1.    Analyzing the Genomic Diversity of Severe Acute Respiratory Syndrome-Coronavirus (Sars-Cov-2) in Bahrain.

The findings of these analyses will be helpful to design and evaluate diagnostic tests, to track and trace the ongoing outbreak, to predict future outbreak and its pattern, and to identify potential national intervention options in Bahrain.

 2. Identification of the Human Genetic Determinants of COVID-19 Susceptibility, Severity and Outcomes in Bahraini Population

2.a Identify genes, pathways, and possible mechanisms related to COVID-19 susceptibility and severity in Bahraini population, and suitable to target with therapeutics.

2.b Identify monogenic errors underlying severe forms of COVID-19.

2.c Identify monogenic determinants of resistance to COVID-19 infection.

3. Developing Screening Test for COVID-19 Susceptibility, Severity and Resistance for Bahraini Population

    4. Developing Bahraini Population Variation Database